COVID-19 in Italy: impact of containment measures and prevalence estimates of infection in the general population
Keywords:
COVID-19, containment, prevalence, mortalityAbstract
Since the beginning of the COVID-19 epidemic in Italy, the Italian Government implemented several restrictive measures to contain the spread of the infection. Data shows that, among these measures, the lockdown implemented as of 9 March had a positive impact, in particular the central and southern regions of Italy, while other actions appeared to be less effective. When the true prevalence of a disease is unknown, it is possible estimate it, based on mortality data and the assumptive case-fatality rate of the disease. Given these assumptions, the estimated period-prevalence of COVID-19 in Italy varies from 0.35% in Sicity to 13.3% in Lombardy.
References
2. European Centre for Disease Prevention and Control (ECDC). Situation update 6 april 2020. https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases (accessed 08.04.20)
3. Lazzerini M, Putoto G. COVID-19 in Italy: momentous decisions and many uncertainties. Lancet Glob Health. 2020 Mar 18. pii: S2214-109X(20)30110-8
4. Signorelli C, Odone A, Oradini-Alacreu A, Pelissero G. Universal Health Coverage in Italy: lights and shades of the Italian National Health Service which celebrated its 40th anniversary. Health Policy. 2020 Jan;124(1):69-74.
5. Boccia S, Ricciardi W, Ioannidis JPA. What Other Countries Can Learn From Italy During the COVID-19 Pandemic. JAMA Intern Med. 2020 Apr 7. doi: 10.1001/jamainternmed.2020.1447. [Epub ahead of print]
6. Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 Epidemic?. The Lancet. Published: 9 March 2020.
7. WHO. Pandemic Influenza Preparedness and Response: A WHO Guidance Document. Geneva: World Health Organization; 2009. 4, The WHO pandemic phases. Available from: https://www.ncbi.nlm.nih.gov/books/NBK143061/
8. Lau H, Khosrawipour V, Kocbach P, Mikolajczyk A, Schubert J, Bania J, Khosrawipour T. The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China. J Travel Med. 2020 Mar 17. pii: taaa037. doi: 10.1093/jtm/taaa037.
9. Gazzetta Ufficiale della Repubblica Italiana, Raccolta degli atti recanti misure urgenti in materia di contenimento e gestione dell'emergenza epidemiologica da COVID-19
10. ISTAT L’andamento dei decessi del 2020. Dati anticipatori sulla base del sistema ANPR. Nota esplicativa 2020 Mar 31
11. UCSC. Coronavirus, le stime dei ricercatori: “In Italia almeno 2800 morti non dichiarati” (to be completed)
12. Oke J, Heneghan C. Global Covid-19 Case Fatality Rates. The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare (CEBM). https://www.cebm.net/covid-19/global-covid-19-case-fatality-rates/ (accessed 07.04.20)
13. Ferguson N, et al. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. 16 Mar 2020; doi.org/10.25561/77482
14. Villa M. La letàlità italiana tra apparenza e realtà. ISPI, 27 3 2020. https://www.ispionline.it/it/pubblicazione/coronavirus-la-letalita-italia-tra-apparenza-e-realta-25563
Downloads
Published
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
